Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia
- PMID: 18548091
- DOI: 10.1038/leu.2008.162
Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia
Abstract
In 1982, chronic myelomonocytic leukemia (CMML) was first classified in the category of myelodysplastic syndromes (MDSs), but it always seemed somewhat out of place compared with the rest of the MDS categories. In the 1990s, many argued that there were two different forms of CMML, a proliferative type and a myelodysplastic type. Then in 2001 the World Health Organization created a new category called the mixed myelodysplastic/myeloproliferative diseases, under which CMML was included. Although we still do not understand much about CMML pathogenesis nor do we have specific therapies for this disease, at least now most agree that it is in an appropriate category such that other areas of investigation can now proceed. On the other hand, we now understand a great deal of the pathogenesis underlying the disease now called juvenile myelomonocytic leukemia (JMML). JMML also fits in the new category of mixed myelodysplastic/myeloproliferative diseases. JMML is an excellent model malignancy for investigating and understanding dysregulated and aberrant signal transduction in the Ras pathway. It has also served as a teaching tool for exploring inherited predispositions to cancer.
Similar articles
-
Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.Int J Lab Hematol. 2010 Dec;32(6 Pt 2):559-71. doi: 10.1111/j.1751-553X.2010.01251.x. Int J Lab Hematol. 2010. PMID: 20670271 Review.
-
Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.Br J Haematol. 2008 Mar;140(6):610-24. doi: 10.1111/j.1365-2141.2007.06958.x. Br J Haematol. 2008. PMID: 18302710 Review.
-
Treatment advances for pediatric and adult onset neoplasms with monocytosis.Curr Hematol Malig Rep. 2021 Jun;16(3):256-266. doi: 10.1007/s11899-021-00622-8. Epub 2021 Mar 16. Curr Hematol Malig Rep. 2021. PMID: 33728588 Review.
-
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.Br J Haematol. 2010 Dec;151(5):460-8. doi: 10.1111/j.1365-2141.2010.08393.x. Epub 2010 Oct 19. Br J Haematol. 2010. PMID: 20955399
-
CMML: a biologically distinct myeloproliferative disease.Curr Hematol Rep. 2003 May;2(3):202-8. Curr Hematol Rep. 2003. PMID: 12901341 Review.
Cited by
-
A 27-Year-Old Patient Fulfilling the Diagnostic Criteria of Both CMML and JMML.Case Rep Oncol Med. 2016;2016:7543582. doi: 10.1155/2016/7543582. Epub 2016 Feb 29. Case Rep Oncol Med. 2016. PMID: 27034866 Free PMC article.
-
A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.Sci Transl Med. 2011 Mar 30;3(76):76ra27. doi: 10.1126/scitranslmed.3001069. Sci Transl Med. 2011. PMID: 21451123 Free PMC article.
-
Myelodysplasia in younger adults: outlier or unique molecular entity?Haematologica. 2017 Jun;102(6):967-968. doi: 10.3324/haematol.2017.165993. Haematologica. 2017. PMID: 28566339 Free PMC article. No abstract available.
-
Highlights of 2008 in bone marrow biopsy pathology.J Hematop. 2009 Mar;2(1):42-4. doi: 10.1007/s12308-009-0025-0. Epub 2009 Feb 24. J Hematop. 2009. PMID: 19669222 Free PMC article. No abstract available.
-
Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.J Pediatr Hematol Oncol. 2014 Aug;36(6):491-4. doi: 10.1097/MPH.0000000000000077. J Pediatr Hematol Oncol. 2014. PMID: 24322499 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
